Motus GI Receives FDA Clearance for Colonoscopy Product

Motus GI’s (NASDAQ:MOTS) latest US Food and Drug Administration (FDA) clearance will strengthen the framework for colonoscopy examinations for more patients than its previously approved product. On Thursday (September 13), Motus announced that its FDA-cleared Pure-Vu Slim Sleeve, which is an extension of its standard Pure-Vu System, will allow the company access to a wider arange […]